Docenti

Paolo Rigotti

Paolo Rigotti

Full Professor

Telefono: +39 0498213173

E-mail: paolo.rigotti@unipd.it

Group Website:

http://www.trapiantirenepancreas.com

Education
1994: Visiting Professor Trauma Center, University of Texas, Houston
1984-1985: Clinical Fellow Division of Immunology and Organ Transplantation, University of Texas, Houston
1982- 1984: Research Fellow  Department of Surgery, University of Cincinnati
1978-1983: Residency in General Surgery at the University of Padova
1972-1978: Medical School at the University of Padova
1967-1972: Grammar School Tito Livio (Padova)

Positions
2014: Director of the Kidney and Pancreas Transplantation Unit (Padova University-Hospital)
December 2014: Full Professor of Surgery at the University of Padova
October 2012: Director of the Residency School of Surgery at the University of Padova
2000: Associate Professor of Surgery at the University of Padova
1988: Assistant Professor of Surgery at the University of Padova
Director of the Kidney and Pancreas Transplantation Unit )Padova University-Hospital)

Clinical and experimental research in the field of organ transplantation, particularly on renal ischemic damage,  xenotransplantation, dual kidney transplantation, immunosuppressive therapy
Author of 175 scientific publications indexed in Pubmed

1. Krämer BK, Charpentier B, Bäckman L, Silva HT Jr, Mondragon-Ramirez G, Cassuto-Viguier E, Mourad G, Sola R, Rigotti P, Mirete JO; Tacrolimus Prolonged Release Renal Study Group. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. Am J Transplant. 2010 Dec;10(12):2632-43

2. Remuzzi G, Cravedi P, Perna A, Dimitrov BD, Turturro M, Locatelli G, Rigotti P, Baldan N, Beatini M, Valente U, Scalamogna M, Ruggenenti P; Dual Kidney Transplant Group. Long-term outcome of renal transplantation from older donors. N Engl J Med. 2006 Jan 26;354(4):343-52

3. Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuño-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M; CARMEN Study Group. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation. 2005 Apr 15;79(7):807-14.

4. Remuzzi G, Lesti M, Gotti E, Ganeva M, Dimitrov BD, Ene-Iordache B, Gherardi G, Donati D, Salvadori M, Sandrini S, Valente U, Segoloni G, Mourad G, Federico S, Rigotti P, Sparacino V, Bosmans JL, Perico N, Ruggenenti P. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial. Lancet. 2004 Aug 7-13;364(9433):503-12.

5. Gaspari F, Ferrari S, Stucchi N, Centemeri E, Carrara F, Pellegrino M, Gherardi G, Gotti E, Segoloni G, Salvadori M, Rigotti P, Valente U, Donati D, Sandrini S, Sparacino V, Remuzzi G, Perico N; MY.S.S. Study Investigators- Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant. 2004 Nov;4(11):1826-35.

6. Krämer BK, Charpentier B, Bäckman L, Silva HT Jr, Mondragon-Ramirez G, Cassuto-Viguier E, Mourad G, Sola R, Rigotti P, Mirete JO; Tacrolimus Prolonged Release Renal Study Group. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. Am J Transplant. 2010 Dec;10(12):2632-43.

7. Ekser B, Furian L, Broggiato A, Silvestre C, Pierobon ES, Baldan N, Rigotti P.Technical aspects of unilateral dual kidney transplantation from expanded criteria donors: experience of 100 patients. Am J Transplant. 2010 Sep;10(9):2000-7.

8. Rigotti P, Ekser B, Furian L, Baldan N, Valente ML, Boschiero L, Motterlini N, Perna A, Remuzzi G, Ruggenenti P. Outcome of renal transplantation from very old donors. N Engl J Med. 2009 Apr 2;360(14):1464-5.

9. Pierobon ES, Sandrini S, De Fazio N, Rossini G, Fontana I, Boschiero L, Gropuzzo M, Gotti E, Donati D, Minetti E, Gandolfo MT, Brunello A, Libetta C, Secchi A, Chiaramonte S, Rigotti P. Optimizing utilization of kidneys from deceased donors over 60 years: five-year outcomes after implementation of a combined clinical and histological allocation algorithm. Transpl Int. 2013 Aug;26(8):833-41